FDA on Safety Information During Clinical Trials
BioSoteria, Inc., Drug Safety and Risk Management Specialists, continue to be at the forefront in responding to the recent announcement of the ruling by FDA on safety information during clinical trials. A recently published article co-authored by BioSoteria’s President & CEO, Sally Van Doren, PharmD and Senior Vice President of Pharmacovigilance and Risk Management, James [...]